Report Details
Introduction
- The USA diagnostic imaging market was valued at USD 8.62 billion in 2025 and is projected to reach USD 10.69 billion by 2030.
- Growth is driven by increasing demand for early disease detection and non‑invasive diagnostic techniques.
- AI‑integrated imaging systems and digital radiology are improving diagnostic efficiency.Expansion of outpatient imaging centers and chronic disease screening programs supports market growth.
USA Diagnostic Imaging Market – PESTEL Analysis (2020–2035)
Political:
- Stable regulatory environment under the FDA and CMS supports consistent safety and quality standards for diagnostic imaging devices.
- Government healthcare programs like Medicare and Medicaid expand access to imaging, particularly for the elderly and underserved.
- Increasing public healthcare spending post-pandemic has bolstered imaging infrastructure and preparedness.
Economic:
- The market is valued at USD 8.62 billion in 2025 and is projected to reach USD 10.69 billion by 2030, growing at a CAGR of 4.4%.
- Rising healthcare expenditures and insurance coverage are enhancing demand for early diagnostics and imaging services.
- Capital-intensive nature of advanced imaging (MRI, PET-CT) impacts adoption in budget-restricted facilities.
Social:
- Growing awareness of early diagnosis and preventive care is driving increased patient demand for diagnostic imaging.
- Rising geriatric population and lifestyle-related diseases such as diabetes, cancer, and cardiovascular conditions are creating higher imaging volumes.
- Patients are increasingly seeking outpatient diagnostic centers for cost-effective and faster services.
Technological:
- Rapid innovation in AI-driven diagnostics, image recognition, and predictive analytics enhances scan accuracy and speeds up diagnosis.
- Advancements in portable, handheld, and point-of-care imaging are expanding access beyond traditional hospital settings.
- Cloud-based PACS (Picture Archiving and Communication System) and tele-imaging platforms are improving remote collaboration and data sharing.
Environmental:
- Imaging centers are adopting energy-efficient devices and radiation dose reduction technologies to ensure sustainability and patient safety.
- Growing push for green healthcare facilities encourages low-emission imaging equipment and safe disposal of contrast agents and materials.
Legal:
- Strict compliance requirements under HIPAA for patient data privacy and secure transmission of diagnostic images.
- Evolving FDA regulatory pathways for AI and software-based imaging diagnostics require continuous updates in compliance protocols.
- Increased litigation risks in misdiagnosis cases underscore the importance of high-quality and accurate imaging systems.
USA Diagnostic Imaging Market
1. By Modality
1.1 X-ray Imaging Systems
• Digital X-ray
• Analog X-ray
• Mammography Systems
1.2 Computed Tomography (CT) Scanners
1.3 Magnetic Resonance Imaging (MRI) Systems
• High-field MRI
• Low-to-mid-field MRI
1.4 Ultrasound Imaging Systems
• 2D Ultrasound
• 3D/4D Ultrasound
• Doppler Ultrasound
1.5 Molecular Imaging Systems
• Positron Emission Tomography (PET)
• Single Photon Emission Computed Tomography (SPECT)
1.6 Hybrid Imaging Systems
• PET/CT
• SPECT/CT
2. By Application
2.1 Cardiology
2.2 Oncology
2.3 Neurology
2.4 Orthopedics & Musculoskeletal
2.5 General Imaging
3. By End User
3.1 Hospitals
3.2 Diagnostic Imaging Centers
3.3 Ambulatory Care Centers
4. By Technology
4.1 Digital Imaging
4.2 Analog/Conventional Imaging
5. By USA Region Segment
5.1 Northeast
5.2 Midwest
5.3 South
5.4 West
6. By Country Segment
6.1 United States of America
Key Players (20):
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems Corporation
- Fujifilm Holdings (Fujifilm Medical Systems)
- Hologic, Inc.
- Carestream Health
- Samsung Medison (Samsung Healthcare)
- Shimadzu Corporation
- Agfa-Gevaert Group
- Mindray Medical International
- Esaote S.p.A.
- Hitachi Healthcare Americas
- Konica Minolta, Inc.
- Planmeca (Imaging)
- Dentsply Sirona (Dental Imaging)
- Varex Imaging Corporation
- Bruker Corporation
- Analogic Corporation
- Curium (Nuclear Imaging)
Chapter 1: Executive Summary
1.1. Market Highlights and Key Figures
1.2. USA Market Size Snapshot (2025–2035)
1.3. Emerging Trends and Key Takeaways
1.4. Analyst Strategic Perspective
Chapter 2: Research Methodology
2.1. Research Design and Scope
2.2. Data Sources and Validation
2.3. Forecasting Model
2.4. Assumptions and Limitations
Chapter 3: Market Overview
3.1. Introduction to Diagnostic Imaging
3.2. Role of Imaging in Modern Medicine
3.3. Market Segmentation
3.4. Market Structure and Value Chain
Chapter 4: Market Dynamics
4.1. Growth Drivers
4.2. Market Restraints
4.3. Key Opportunities
4.4. Technology Disruption Impact
4.5. Regulatory Trends Impact
Chapter 5: USA Diagnostic Imaging Market Outlook (2020–2035)
5.1. Market Size by Value (USD Million)
5.2. Y-o-Y Growth and CAGR (2025–2035)
5.3. Demand Forecast Across Modalities
5.4. Investment Trends in Imaging Infrastructure
Chapter 6: Segmentation – By Imaging Modality
6.1. X-ray Imaging Systems
6.2. Ultrasound Systems
6.3. Computed Tomography (CT)
6.4. Magnetic Resonance Imaging (MRI)
6.5. Nuclear Imaging (PET, SPECT)
6.6. Mammography
6.7. Fluoroscopy
6.8. Others
Chapter 7: Segmentation – By Application
7.1. Cardiology
7.2. Oncology
7.3. Neurology
7.4. Orthopedics
7.5. Gynecology
7.6. General Imaging
7.7. Others
Chapter 8: Segmentation – By Technology
8.1. 2D Imaging
8.2. 3D & 4D Imaging
8.3. Digital Imaging Systems
8.4. AI-Based Diagnostic Imaging
Chapter 9: Segmentation – By End User
9.1. Hospitals
9.2. Diagnostic Imaging Centers
9.3. Ambulatory Surgical Centers
9.4. Specialty Clinics
9.5. Academic and Research Institutes
Chapter 10: Regional Analysis – USA
10.1. Northeast
10.2. Midwest
10.3. South
10.4. West
Chapter 11: Technological Advancements
11.1. AI in Diagnostic Imaging
11.2. Portable and Mobile Imaging Systems
11.3. Cloud-Based Image Storage (PACS/RIS)
11.4. Radiation Dose Reduction Technologies
Chapter 12: Regulatory Environment
12.1. FDA Guidelines and Device Classifications
12.2. HIPAA and Patient Data Compliance
12.3. Medicare/Medicaid Imaging Coverage
Chapter 13: Pricing and Reimbursement Analysis
13.1. Cost Benchmarking by Imaging Type
13.2. Reimbursement Coverage and Trends
13.3. Public vs. Private Payer Analysis
Chapter 14: Competitive Landscape
14.1. Market Share Analysis
14.2. Competitive Positioning of Key Vendors
14.3. Strategic Partnerships and M&A
14.4. Innovation and Product Launches
Chapter 15: Company Profiles
15.1. GE HealthCare
15.2. Siemens Healthineers
15.3. Philips Healthcare
15.4. Canon Medical Systems
15.5. Fujifilm Holdings
15.6. Carestream Health
15.7. Hitachi Medical Systems
15.8. Hologic, Inc.
15.9. Shimadzu Corporation
15.10. Other Noteworthy Players
Chapter 16: SWOT Analysis
16.1. Industry SWOT Overview
16.2. SWOT for Leading Companies
Chapter 17: Porter’s Five Forces Analysis
17.1. Threat of New Entrants
17.2. Supplier Power
17.3. Buyer Power
17.4. Substitution Risk
17.5. Competitive Rivalry
Chapter 18: PESTEL Analysis
18.1. Political
18.2. Economic
18.3. Social
18.4. Technological
18.5. Environmental
18.6. Legal
Chapter 19: Future Trends & Outlook
19.1. Rise of AI and Cloud Imaging
19.2. Integration with EMR/EHR Platforms
19.3. Expansion of Imaging-as-a-Service Models
Chapter 20: Investment and Opportunity Analysis
20.1. Growth Potential by Modality
20.2. Regional Hotspots for Expansion
20.3. Private Equity and VC Investment Trends
Chapter 21–30: Appendices and References
- Glossary
- Abbreviations
- Methodology Summary
- Supporting Tables
- Charts and Figures Index
- Research Notes
- Data Sources
- About the Publisher
- Contact Details
- Disclaimer
1. By Modality
1.1 X-ray Imaging Systems
• Digital X-ray
• Analog X-ray
• Mammography Systems
1.2 Computed Tomography (CT) Scanners
1.3 Magnetic Resonance Imaging (MRI) Systems
• High-field MRI
• Low-to-mid-field MRI
1.4 Ultrasound Imaging Systems
• 2D Ultrasound
• 3D/4D Ultrasound
• Doppler Ultrasound
1.5 Molecular Imaging Systems
• Positron Emission Tomography (PET)
• Single Photon Emission Computed Tomography (SPECT)
1.6 Hybrid Imaging Systems
• PET/CT
• SPECT/CT
2. By Application
2.1 Cardiology
2.2 Oncology
2.3 Neurology
2.4 Orthopedics & Musculoskeletal
2.5 General Imaging
3. By End User
3.1 Hospitals
3.2 Diagnostic Imaging Centers
3.3 Ambulatory Care Centers
4. By Technology
4.1 Digital Imaging
4.2 Analog/Conventional Imaging
5. By USA Region Segment
5.1 Northeast
5.2 Midwest
5.3 South
5.4 West
6. By Country Segment
6.1 United States of America
Key Players (20):
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems Corporation
- Fujifilm Holdings (Fujifilm Medical Systems)
- Hologic, Inc.
- Carestream Health
- Samsung Medison (Samsung Healthcare)
- Shimadzu Corporation
- Agfa-Gevaert Group
- Mindray Medical International
- Esaote S.p.A.
- Hitachi Healthcare Americas
- Konica Minolta, Inc.
- Planmeca (Imaging)
- Dentsply Sirona (Dental Imaging)
- Varex Imaging Corporation
- Bruker Corporation
- Analogic Corporation
- Curium (Nuclear Imaging)
Download Sample Request Form
Make an Inquiry
Ask for Discount
Frequently Asked Questions
How large will the U.S. diagnostic imaging market be by 2030?
The U.S. diagnostic imaging market is projected to grow from USD 8.62 billion in 2025 to approximately USD 10.69 billion by 2030, registering a CAGR of 4.4%, driven by increased adoption of advanced imaging technologies across healthcare facilities.
What imaging modalities are driving the U.S. market growth?
High-impact modalities include MRI, CT scans, X-rays, ultrasound, and PET imaging, with growing integration of AI-enhanced image processing and cloud-based diagnostics.
What factors are boosting demand for diagnostic imaging services in the USA?
Key growth drivers include rising chronic disease prevalence, aging population, expansion of outpatient imaging centers, and adoption of early detection protocols in preventive care.
Which sectors are the primary users of diagnostic imaging equipment in the U.S.?
Hospitals, ambulatory care centers, specialized diagnostic imaging clinics, and tele-radiology service providers are major buyers of imaging systems across the country.
Who are the major players in the U.S. diagnostic imaging market?
Leading companies include GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Fujifilm, offering cutting-edge systems and integrated AI capabilities.